SCHEMBL21386468

SCHEMBL21386468

Nc1nn(C(=O)CCCCCCCCCCCNC(=O)CCC(=O)O)c2cccc(-c3ccc(NC=O)cc3)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.37
FLT3 P36888 3/20 0.37
HDAC3 O15379 6/20 0.36
HDAC1 Q13547 6/20 0.36
HDAC4 P56524 5/20 0.36
HDAC7 Q8WUI4 5/20 0.36
HDAC2 Q92769 5/20 0.36
HDAC10 Q969S8 5/20 0.36
HDAC11 Q96DB2 5/20 0.36
HDAC8 Q9BY41 5/20 0.36
HDAC6 Q9UBN7 5/20 0.36
HDAC9 Q9UKV0 5/20 0.36
HDAC5 Q9UQL6 5/20 0.36
TAAR1 Q96RJ0 1/20 0.35
LCK P06239 1/20 0.34
CSF1R P07333 1/20 0.34
KIT P10721 1/20 0.34
FLT1 P17948 1/20 0.34
FLT4 P35916 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21386473 0.80 KDR (0.64) KDRFLT3HDAC1HDAC6LCK
SCHEMBL21668695 0.80 KDR (0.64) KDRFLT3HDAC1HDAC6LCK
SCHEMBL21668629 0.79 HDAC3 (0.38) KDRFLT3HDAC3HDAC1HDAC4
SCHEMBL24486690 0.70 KDR (0.56) KDRFLT3HDAC1HDAC6LCK
SCHEMBL24486699 0.70 KDR (0.56) KDRFLT3HDAC1HDAC6LCK
SCHEMBL21386467 0.70 KDR (0.61) KDRFLT3HDAC1HDAC6LCK
SCHEMBL21668601 0.70 KDR (0.61) KDRFLT3HDAC1HDAC6LCK
SCHEMBL28428802 0.69 KDR (0.72) KDRFLT3HDAC1HDAC6LCK
SCHEMBL29967987 0.68 MEN1 (0.37) KDRFLT3HDAC3HDAC1HDAC2
SCHEMBL14981887 0.59 HDAC4 (0.71) HDAC3HDAC1HDAC4HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3543228-B1 COMPOUND HAVING ANTICANCER ACTIVITY, AND PREPARATION METHOD AND APPLICATION THEREOF 3D MEDICINES BEIJING CO LTD (CN) 2022-12-28 EP disclosed
EP-3543228-A1 COMPOUND HAVING ANTICANCER ACTIVITY, AND PREPARATION METHOD AND APPLICATION THEREOF 3D Medicines (Beijing) Co., Ltd. (CN) 2019-09-25 EP disclosed